One potential vaccine, GVAX pancreas, has been formulated with allogeneic pancreatic tumor cells that secrete granulocyte-macrophage colony-stimulating factor (GM-CSF) to induce T cell infiltration of the pancreatic tumor. The gene discussed is CSF2; the disease is pancreatic neoplasm.